Time: 11:00 AM - 12:30 PM PST Join Galapagos for an in-person KOL event during the 65th ASH Annual Meeting…
Join Codexis for a virtual KOL event featuring John Maraganore, PhD (Founder and Former Chief Executive Officer of Alnylam Pharmaceuticals) and David Butler, PhD (Chief…
Join Lumos Pharma for a virtual KOL event featuring Andrew Dauber, M.D., M.M.Sc.,(Children’s National Hospital), Fernando Cassorla, M.D. (Institute of…
Join us for a virtual KOL event with Sol-Gel Technologies, featuring Julie Breneiser (Executive Director, Gorlin Syndrome Alliance) and Ervin Epstein Jr., MD…
Join AcelRx Pharmaceuticals (Nasdaq: ACRX) for a KOL panel discussion on the anticoagulant market for dialysis and the Niyad NEPHRO…
Join us for a virtual KOL event with Kineta, featuring immunology expert Michael A. Curran, PhD (MD Anderson Cancer Center Department…
Join Gamida Cell for a virtual fireside chat with thought leader Gary Schiller, MD, FACP, Professor of Medicine and Director of the Hematological Malignancy/Stem…
Join BiomX for a virtual KOL event, featuring Dr. Eitan Kerem, M.D. (Hadassah University Medical Center) and Dr. Robert T. “Chip” Schooley,…
Join us for a virtual KOL Event with BioAtla, featuring Carl M. Gay, MD, PhD (MD Anderson Cancer Center) who will review…
Join IDEAYA Biosciences for a virtual Investor R&D day featuring GSK and a KOL, showcasing scientific insights and clinical development…

Join Immix Biopharma and key opinion leaders Heather Landau, MD (Director of Amyloidosis Program, Memorial Sloan-Kettering Cancer Center), Vaishali Sanchorawala, MD (Professor,…
Join us for a virtual KOL event to discuss new data from the ongoing Phase 2 ReSPECT-GBM trial of rhenium…
Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…
Join us for a virtual KOL event with ALIGOS Therapeutics, featuring Mark Sulkowski, MD (Johns Hopkins University School of Medicine)…
Join us for an evening of networking, cocktails, and hors d'oeuvres hosted by LifeSci Partners during the Jefferies London Healthcare…
Join Arrowhead Pharmaceuticals for a virtual analyst and investor event reviewing the new Phase 2 clinical data from the ongoing…